clofibric acid has been researched along with Acute Myelogenous Leukemia in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fenton, SL | 1 |
| Drayson, MT | 1 |
| Hewison, M | 1 |
| Vickers, E | 1 |
| Brown, G | 1 |
| Bunce, CM | 1 |
1 other study available for clofibric acid and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Clofibric acid: a potential therapeutic agent in AML and MDS.
Topics: Aged; Antineoplastic Agents; Clofibric Acid; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Middle A | 1999 |